Guides
Vitamin D Deficiency: What Level Is Normal and What Is Dangerous?
According to TEMD 2025, vitamin D (25-OH D) below 20 ng/mL is insufficient, and at 12 and below the risk of osteomalacia increases; 20–50 ng/mL is sufficient.
Translated from the Turkish original by Doktorclub. The Turkish version is the reference text; this English translation has not been separately reviewed by a physician. Read the Turkish original.

Key takeaway
Vitamin D status is measured in the blood with 25-hydroxyvitamin D, 25(OH)D for short. According to the 2025 guideline of the Society of Endocrinology and Metabolism of Türkiye (TEMD), below 20 ng/mL is insufficient and requires treatment. 12 ng/mL and below increases the risk of osteomalacia; 20–50 ng/mL is the sufficient and safe range. The Endocrine Society 2024 guideline, for its part, does not recommend routine testing in the healthy general population and does not define a target level for disease prevention. When interpreting your result, the laboratory reference range on your report applies.
Short Answer
According to TEMD 2025, vitamin D (25-OH D) below 20 ng/mL is insufficient, and at 12 and below the risk of osteomalacia increases; 20–50 ng/mL is sufficient.
Vitamin D status is measured in the blood with 25-hydroxyvitamin D, 25(OH)D for short. According to the 2025 guideline of the Society of Endocrinology and Metabolism of Türkiye (TEMD), below 20 ng/mL requires treatment. A low result is not an emergency on its own. The Endocrine Society 2024 guideline, for its part, does not recommend routine testing in healthy people and does not define a target level for protection from disease.
This page is for reading a lab result. Who should start a supplement and when is explained in the supplement article, and a high result in the excess and toxicity article.
What does your result mean?
The thresholds are from the TEMD 2025 guideline. The nmol/L equivalents were calculated with the NIH factor "1 ng/mL = 2.5 nmol/L".
| 25(OH)D (ng/mL) | nmol/L | What does it mean? | Usual next step |
|---|---|---|---|
| 12 and below | 30 and below | The risk of osteomalacia in adults and rickets in children increases | The doctor requests calcium, phosphorus, ALP and PTH. TEMD recommends that treatment at this level start with a loading dose. |
| Above 12 – below 20 | Above 30 – below 50 | Insufficient; requires treatment | The doctor determines the cause and the treatment plan. |
| 20–29 | 50–74 | In the sufficient range according to TEMD | If there is osteoporosis or a risk of falls, the doctor may want a higher target. |
| 30–50 | 75–125 | Sufficient and safe | No further action is needed. |
| 50–100 | 125–250 | Above TEMD's safe range; according to NIH, above 50 ng/mL may be associated with adverse effects | Review all the vitamin D-containing products you use with your doctor. |
| Above 100 | Above 250 | The risk of toxicity increases | Stop the supplement in consultation with your doctor; calcium is measured. |
| Above 150 | Above 375 | Symptoms of hypercalcemia are seen | See a doctor the same day; emergency department if there is vomiting; if there is clouded consciousness, call 112 (in Türkiye) or your local emergency number. |
These are decision limits, not a reference range. The guideline thresholds were derived from bone health studies, not from the average of healthy people. For this reason the laboratory range on your report may be slightly different. Your doctor uses the guideline threshold and your risk status together.
30 or 20? Why do the guidelines differ?
| Source | What does it say? |
|---|---|
| TEMD 2025 | 20–50 ng/mL is sufficient. It states openly that there is no consensus on the optimal level. |
| IOM 2011 | 20 ng/mL meets the bone health needs of at least 97.5% of the population. |
| BHOF (formerly the US National Osteoporosis Foundation), International Osteoporosis Foundation, American Geriatrics Society | Above 30 ng/mL to reduce the risk of falls and fractures. |
| Endocrine Society 2024 | Does not define a disease-preventing target level for the healthy general population. |
So a result of 24 ng/mL is sufficient according to TEMD. In a patient with osteoporosis, the doctor may still aim for above 30. Both decisions are in line with guidelines.
How does it look on your report?
The line below is an example; the format on your report may be slightly different.
| Test | Result | Unit | Reference |
|---|---|---|---|
| 25-Hidroksi Vitamin D | 14.2 | µg/L | Varies by laboratory |
This result is the same number as in ng/mL, that is 14.2 ng/mL. It falls in the "Above 12 – below 20" band of the table: insufficient, requires treatment. If the same result were written in nmol/L, it would be about 35.5.
- Test name: "25-Hidroksi vitamin D" (25-hydroxyvitamin D), "25(OH)D" or "25-OH Vitamin D". Do not confuse this with "1,25-Dihidroksi vitamin D" (1,25-dihydroxyvitamin D). According to TEMD 2025, the half-life of 1,25-dihydroxy D is very short and it is not used in diagnosing deficiency. It is requested only in some hereditary bone diseases and granulomatous diseases.
- Unit: In the national unit standard of the Ministry of Health of Türkiye, the unit for 25(OH)D is µg/L. This is numerically the same as ng/mL.
- Starred values: According to the Ministry's Decision Limit Procedure, decision limits are marked with an asterisk (*) on the report. Vitamin D is not on the Ministry's priority list; the laboratory specialist can add a decision limit according to the method.
- Difference in method: TEMD 2025 notes that the most reliable methods are liquid chromatography and mass spectrometry. Results may differ slightly between laboratories. If possible, do the follow-up in the same laboratory.
To enter your result and see its band you can use the lab result interpreter. For the other tests, see the Lab Test Guide.
Below what level is it dangerous, and what are the symptoms?
There is no single "danger number". TEMD 2025 describes the levels at which risk increases:
- Below 20 ng/mL: The data showing that bone health is adversely affected are strong. PTH (parathyroid hormone) rises in 40% of those at this level.
- 12 ng/mL and below: The risk of osteomalacia (softening of the bones in adults) and rickets increases.
- Below 10 ng/mL: A rise in PTH is seen in 51%. Long-standing high PTH speeds up bone loss.
According to TEMD 2025, most people with deficiency have no symptoms. Calcium, phosphorus and alkaline phosphatase are also mostly normal. In severe and long-standing deficiency the following can develop:
- Widespread bone and muscle pain, tenderness when the bones are pressed
- Weakness in the hip and thigh muscles, difficulty walking, falls
- Fractures and reduced bone density
- In children, bowing of the legs and growth problems (rickets)
Tiredness, hair loss, frequent infections and depression are not specific to vitamin D deficiency. Endocrine Society 2024 emphasizes that the relationship between vitamin D level and many diseases has not been proven to be cause and effect. The cause of these complaints should be investigated separately. For tiredness and paleness, for example, see the article iron deficiency anemia.
Emergency in low vitamin D: Muscle spasms, numbness around the mouth and in the fingers, or a seizure suggest low calcium. In this case call 112 (in Türkiye) or your local emergency number.
Reasons for a low result
- Little sun: According to TEMD, 80–90% of vitamin D is made in the skin with sunlight; only 10–20% is obtained from food. In Türkiye, production in the skin takes place from mid-March to mid-October and between 10:00 and 16:00. Working indoors, covering clothing and dark skin reduce production; sunbathing behind glass or a net curtain, however, prevents production. Seasonal details are in the supplement article.
- Weight and age: Obesity, especially a large waist circumference. Production in the skin decreases in older age.
- Absorption problems: Celiac disease, inflammatory bowel diseases, pancreatic insufficiency, stomach surgery and obesity surgery. Details: vitamin deficiency after obesity surgery.
- Liver and kidney disease: Conversion to the active form is impaired. In nephrotic syndrome the protein that carries vitamin D is lost in the urine.
- Medicines: TEMD's list includes epilepsy medicines such as phenytoin, phenobarbital and carbamazepine; rifampicin and isoniazid; ketoconazole; some HIV medicines; and corticosteroids such as dexamethasone. Do not stop these medicines on your own.
Deficiency is very common in Türkiye. TEMD 2025 reports a frequency of 63% in the general population in a meta-analysis covering 40 studies. According to TEMD, foods with added vitamin D are also limited in Türkiye.
Who should be tested, and for whom is it unnecessary?
The two guidelines point the same way: not everyone is screened.
- Endocrine Society 2024: It does not recommend routine 25(OH)D testing in any of the groups it examined. This includes pregnant women, people over 75, and those with obesity or dark skin. For some groups it recommends supplementation directly instead of testing.
- TEMD 2025: It does not recommend population screening; it recommends the test only in people at high risk of deficiency. Routine measurement is not recommended in pregnant women.
| Situation | Is the test meaningful? |
|---|---|
| Older people, people who cannot leave the house, people who work at night or indoors | Can be considered (TEMD risk group) |
| Diabetes, chronic kidney, liver or parathyroid disease, malabsorption | Can be considered |
| Obesity or a history of obesity surgery | Can be considered |
| Use of a medicine that increases the breakdown of vitamin D | Can be considered |
| Osteoporosis, fracture with minor trauma, suspected osteomalacia | Can be considered |
| Healthy adult with no risk and no complaints, "annual check-up" | Mostly unnecessary |
| People who have been taking a regular supplement of up to 2,000 IU a day for a long time | TEMD does not recommend routine monitoring |
| Only tiredness or hair loss, no other risk | Mostly unnecessary |
To see whether you are in a risk group you can use the deficiency risk test. If you are in a risk group, the first assessment is made by a family physician or an Internal Medicine specialist.
Reading together with the other tests
Vitamin D is mostly interpreted together with calcium, PTH and ALP.
| Pattern seen together | What does it suggest? | Whom to see? |
|---|---|---|
| Low D, high PTH, normal calcium | Secondary hyperparathyroidism; can speed up bone loss | Family physician or Internal Medicine |
| D below 10–12 ng/mL, high ALP and PTH, low calcium and phosphorus | According to TEMD 2025, favors nutritional osteomalacia | Endocrinology |
| High D, high calcium, suppressed PTH | Toxicity due to supplements. See vitamin D excess | A doctor the same day |
| Calcium and PTH both high after treatment | According to TEMD 2025, unrecognized primary hyperparathyroidism may have come to light | Endocrinology |
| D, B12 and ferritin all low | An absorption problem such as celiac disease. See B12 deficiency and ferritin | Gastroenterology |
| Low calcium, magnesium also low | Calcium may not be corrected unless magnesium is corrected. See magnesium deficiency | Family physician or Internal Medicine |
For a detailed reading of the calcium result, see the article low and high calcium.
When should you have the test? Common mistakes
- Asking for the wrong test: For vitamin D status, 25(OH)D is checked, not 1,25-dihydroxy D.
- Mixing up the unit: A result of "50" written in nmol/L is not the same value as 50 in ng/mL: it equals 20 ng/mL. According to TEMD, below 20 is insufficient; exactly 20 is the lower limit of the sufficient range. On reports from abroad, look at the unit.
- Comparing seasons: In the Bursa data reported by TEMD 2025, deficiency in women was 80.7% in the March–May period and 69.9% in the September–November period. A March result and a September result can differ in the same person. Do the follow-up in the same season.
- Repeating too early: The half-life of 25(OH)D is 2–3 weeks. Measuring one month after a supplement does not show the full effect of treatment.
- Thinking "higher is better": TEMD's safe range ends at 50 ng/mL.
- Not mentioning biotin: In some laboratories 25(OH)D is measured with an antibody-based (immunological) method. High-dose biotin can distort these tests. See does biotin distort test results?
- Hiding supplements: Tell your doctor about all vitamin D-containing products, including multivitamins, calcium tablets and omega-3, and their amount and frequency.
For fasting, follow your laboratory's instructions. If calcium and phosphorus are also in the same panel, you may be asked to come fasting in the morning.
If it came back low: timeline from measurement to follow-up
Your doctor determines the form and amount of treatment. The general principles of TEMD 2025 are as follows: oral cholecalciferol (D3) is preferred. Intermittent or single high-dose injections are not recommended because they increase the risk of falls and fractures. The target in treatment is 20–50 ng/mL.
| Time | What happens? |
|---|---|
| Day of the result | The doctor assesses the band, the symptoms and the causes. At 12 and below, calcium, phosphorus, ALP and PTH are requested. |
| First weeks | Treatment starts. The blood level rises slowly; an early measurement is misleading. |
| Week 8–12 | According to TEMD, the follow-up measurement after loading treatment is done in this interval. |
| 90 days | According to the Ministry of Health's 2024 guide, the shortest repeat-request interval for 25(OH)D in outpatient visits. The doctor can request it earlier with a justification. |
| Afterwards | The maintenance dose and whether a repeat measurement is needed are determined according to risk status. |
Dose ranges for prevention and treatment, and the groups who can receive supplementation without testing, are explained in the supplement article. Whether calcium is needed for bone is covered in the article calcium supplements. If osteomalacia is suspected or there is high calcium or a PTH disorder, an Endocrinology assessment is needed; if a child has bowing of the legs, a Pediatrics assessment is needed.
What has changed?
- 12 November 2026: The threshold wording was aligned with TEMD 2025: insufficiency is "below 20 ng/mL", the risk of osteomalacia is "12 ng/mL and below". The overlap between the bands in the table was removed.
- 28 October 2026: A report example with numbers, a table of guideline differences, a test decision table and a timeline from measurement to follow-up were added. Which specialist to see was added to the "reading together" section.
- October 2026: It was corrected that a result of 50 written in nmol/L equals 20 ng/mL and is at the lower limit of the sufficient range. The threshold table was turned into a decision table; it was explained that the guideline thresholds are decision limits.
- The thresholds are given according to the TEMD 2025 guideline; the recommendations on routine testing and target level according to Endocrine Society 2024.
Sources
- Türkiye Endokrinoloji ve Metabolizma Derneği [Society of Endocrinology and Metabolism of Türkiye, TEMD]. Osteoporoz ve Metabolik Kemik Hastalıkları Tanı ve Tedavi Kılavuzu [Guideline for the Diagnosis and Treatment of Osteoporosis and Metabolic Bone Diseases]. 2025, 17th edition. https://file.temd.org.tr/Uploads/publications/guides/documents/OSTEPOROZ_nisan2025.pdf (accessed 23 October 2026)
- Demay MB et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2024;109:1907-1947. https://doi.org/10.1210/clinem/dgae290 (accessed 23 October 2026)
- Ross AC et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine. J Clin Endocrinol Metab 2011;96:53-58. https://doi.org/10.1210/jc.2010-2704 (accessed 2 October 2026)
- NIH Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. Updated 27 June 2025. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ (accessed 23 October 2026)
- T.C. Sağlık Bakanlığı SHGM [Ministry of Health of Türkiye, General Directorate of Health Services]. Tıbbi Biyokimya Toplam Test Süreci Rehberi [Medical Biochemistry Total Testing Process Guide]. May 2024, Publication No. 1287. https://dosyamerkez.saglik.gov.tr/Eklenti/48692/0/tibbi-biyokimya-toplam-test-sureci-rehberipdf.pdf (accessed 23 October 2026)
- T.C. Sağlık Bakanlığı SHGM [Ministry of Health of Türkiye, General Directorate of Health Services]. Test Ölçüm Birimleri, Versiyon 2 [Test Measurement Units, Version 2]. 2021. https://dosyamerkez.saglik.gov.tr/Eklenti/41467/0/test-olcum-birimleri-versiyon-2-pdfpdf.pdf (accessed 23 October 2026)
- T.C. Sağlık Bakanlığı SHGM [Ministry of Health of Türkiye, General Directorate of Health Services]. Karar Sınırı (Eşik Değer), Kritik Değer (Panik Değer) ve Ölçüm Birimlerinin Harmonizasyonu Prosedürü [Procedure for the Harmonization of Decision Limits (Threshold Values), Critical Values (Panic Values) and Measurement Units]. 2020. https://dosyamerkez.saglik.gov.tr/Eklenti/15143/0/karar-siniri-esik-deger-kriek42009846pdf.pdf (accessed 23 October 2026)
- 112 Acil Çağrı Merkezi [112 Emergency Call Center]. Resmî internet sitesi [Official website]. 2026. https://www.112.gov.tr/ (accessed 2 October 2026)
Frequently asked questions
My vitamin D came back below 20. Is that dangerous?
It is not an emergency, but it requires treatment. According to the Society of Endocrinology and Metabolism of Türkiye (TEMD) 2025, below 20 ng/mL is insufficient; at 12 ng/mL and below the risk of osteomalacia increases. Your doctor determines the form and amount of treatment.
What should vitamin D be, 20 or 30?
For TEMD 2025, 20–50 ng/mL is sufficient. Some osteoporosis and geriatrics organizations argue for above 30 ng/mL to reduce the risk of falls and fractures. Endocrine Society 2024, for its part, does not define a target level for healthy people.
The report says 50 nmol/L. Is my vitamin D low?
According to TEMD 2025 it is not counted as low, but it is borderline: 50 nmol/L equals 20 ng/mL, and 20–50 ng/mL is the sufficient range. The conversion factor is 1 ng/mL = 2.5 nmol/L. There is no consensus on the optimal level; if there is osteoporosis or a risk of falls, the doctor may want a higher target.
Should everyone have a vitamin D test?
No. Endocrine Society 2024 does not recommend routine testing in any group; TEMD 2025 also does not recommend population screening. The test is considered in high-risk people such as older people, those with malabsorption and those who have had obesity surgery.
When is it measured again after a vitamin D supplement?
TEMD 2025 recommends measuring 8–12 weeks after loading treatment. The half-life of 25(OH)D is 2–3 weeks; measuring after one month does not show the full effect. Routine monitoring is not recommended in those who have been taking up to 2,000 IU a day for a long time.
Does sunbathing behind glass make vitamin D?
No. According to TEMD 2025, sunbathing behind glass or a net curtain prevents production. In Türkiye, production in the skin takes place only from mid-March to mid-October, between 10:00 and 16:00.



